Xtant Medical Holdings price target set at $1 by LUCID Capital Markets
Benzinga reports a ratings action for Xtant Medical Holdings, with a $1.00 per-share price target announced by LUCID Capital Markets.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.